Maharashtra FDA GMP Action: Key Lessons for Pharma Facility Design and Compliance 

GMP compliance is not simply about passing an inspection. It is about creating systems, processes, facilities, and quality practices that consistently support safe and reliable manufacturing.

A recent regulatory action by the Maharashtra Food and Drug Administration (FDA) has once again highlighted the importance of Good Manufacturing Practices (GMP), documentation, quality control, and manufacturing infrastructure.

The Maharashtra FDA permanently cancelled the manufacturing licence of Pune-based Inducare Pharma Pvt. Ltd. following inspections that reportedly identified multiple deficiencies related to manufacturing practices, documentation, quality control, facility maintenance, and GMP compliance. Reports also stated that six Ayurvedic medicines manufactured by the company were declared Not of Standard Quality (NSQ).

For pharmaceutical manufacturers, the case offers an important lesson: quality is not the responsibility of one department alone. People, processes, equipment, utilities, documentation, quality systems, and the physical facility all need to work together.

What Happened at the Pune Manufacturing Facility?

According to reports on the Maharashtra FDA action, inspections identified several deficiencies related to applicable regulatory requirements and GMP provisions for Ayurvedic medicines under Schedule T.

The reported findings included:

• Incomplete or inconsistent Batch Manufacturing Records
• Missing raw-material batch numbers and analysis references
• Gaps in manufacturing documentation
• Missing cleaning and machinery records
• Incomplete process-validation documentation
• Missing quality-testing records
• Inadequate microbiological testing infrastructure and records
• Poor cleanliness in production areas
• Damaged flooring and equipment
• Unclean suction filters
• Gaps in pest-control records
• Inadequate temperature and humidity monitoring
• Missing packaging-material records
• Gaps in distribution and product traceability

Reports further stated that six products were declared Not of Standard Quality, with findings reportedly involving microbial contamination, foreign impurities, insects or larvae, and failures against prescribed testing requirements.

Following regulatory proceedings, including inspections, a show-cause notice, a hearing, and further assessment, the manufacturing licence was permanently cancelled.

The case demonstrates why GMP needs to be treated as an integrated manufacturing system, rather than simply a documentation requirement.

What Can Pharmaceutical Manufacturers Learn From This GMP Action?

A regulatory action involving documentation and quality failures can easily be viewed as a quality-control problem.

However, the larger lesson is that manufacturing quality depends on how the entire facility operates.

1. The facility must support the process.
2. The utilities must support the facility.
3. The equipment must support the process.
4. The documentation must support traceability.
5. The quality system must monitor and control the operation.

If one part of this system is poorly planned or maintained, it can affect other areas of manufacturing.

This is why GMP considerations should be incorporated during pharmaceutical facility planning, rather than addressed only when a facility is preparing for an inspection.

How Facility Design Supports GMP Compliance in Pharmaceutical Manufacturing 

A pharmaceutical facility should do more than provide space for equipment and employees. Its design should support manufacturing processes, hygiene, controlled movement, environmental conditions, cleaning, maintenance, quality control, and future operational requirements.

1. Material and Personnel Flow

The movement of raw materials, packaging materials, finished products, waste, and personnel should be carefully planned.

A logical flow can help minimize unnecessary movement and reduce the risk of mix-ups and cross-contamination.

A typical manufacturing flow may involve:

Receiving → Storage → Dispensing → Manufacturing → Packaging → Finished Goods → Dispatch

The exact arrangement, however, should depend on the products, processes, facility size, and applicable requirements.

2. Zoning and Segregation

Different manufacturing activities may require different levels of environmental and operational control.

Effective zoning establishes appropriate relationships between production, storage, laboratory, personnel, material, and support areas.

During GMP facility design, these relationships should be considered alongside the manufacturing process rather than treated as an architectural exercise alone.

3. Hygienic and Maintainable Design

Floors, walls, ceilings, doors, equipment interfaces, drains, and other building elements should be considered from a cleaning and maintenance perspective.

A space that is difficult to clean, inspect, or maintain can create challenges throughout the facility’s operational life.

Good design therefore considers not only how a room will be used, but also how it will be cleaned, inspected, maintained, and modified.

4. HVAC and Environmental Control

Temperature, humidity, filtration, pressure relationships, airflow, and environmental monitoring should be evaluated according to the manufacturing process and applicable requirements.

HVAC should not be viewed as an isolated MEP system.

It forms part of the manufacturing environment and needs to be coordinated with room layouts, equipment, personnel movement, material flow, and process requirements.

This makes coordinated Plant Engineering particularly important during pharmaceutical facility development.

5. QC and Microbiology Infrastructure

Quality-control and microbiology activities require appropriately planned spaces, equipment, utilities, workflows, and environmental conditions.

Laboratory planning should begin by understanding:

• What needs to be tested?
• How will testing be performed?
• What equipment is required?
• What environmental conditions are needed?
• How will samples move through the facility?

A well-planned QC environment can support the quality system while reducing operational bottlenecks.

6. Equipment and Utilities

Manufacturing equipment and critical utilities should be planned together.

Depending on the facility, utilities may include HVAC, purified water, WFI, compressed air, clean steam, electrical systems, process gases, drainage, and other supporting systems.

Equipment layouts should also provide adequate access for operation, cleaning, inspection, maintenance, and replacement.

An experienced Engineering Consultant can help coordinate these requirements during design and reduce the likelihood of costly modifications during construction.

Why GMP Compliance Starts With Pharmaceutical Facility Design

One of the most important lessons for pharmaceutical facility developers is simple:

GMP compliance should influence facility decisions from the beginning.

A typical facility development process may involve:

Process Understanding → Concept Planning → GMP Assessment → Facility Planning → Zoning & Flow → HVAC/MEP & Utility Planning → Equipment Integration → Construction → Commissioning & Qualification

When these activities are planned independently, problems can emerge later.

For example:

• A room may lack sufficient maintenance access.
• Utility systems may be difficult to service.
• Material and personnel movement may conflict.
• HVAC requirements may not align with the final layout.
• QC areas may not adequately support testing requirements.
• Equipment may require additional infrastructure after installation.

Addressing such issues during construction is generally more disruptive and expensive than identifying them during design.

What Should Manufacturers Review in Their Existing Facility?

Whether developing a new plant or upgrading an existing facility, manufacturers should regularly evaluate whether their infrastructure continues to support current processes and GMP expectations.

Some useful questions include:

• Is material movement logical and controlled?
• Are personnel and material flows appropriately separated?
• Can production areas be effectively cleaned and maintained?
• Are temperature and humidity adequately controlled?
• Does the HVAC system support manufacturing requirements?
• Are QC and laboratory facilities sufficient?
• Are critical utilities accessible for maintenance?
• Is equipment positioned appropriately for cleaning and servicing?
• Are storage and quarantine areas properly planned?
• Can the facility support future production requirements?

These questions encourage manufacturers to move from a reactive approach toward proactive facility and GMP improvement.

How Collabtec Supports GMP-Focused Pharmaceutical Facility Development

At Collabtec, pharmaceutical facility development is approached as an integrated exercise involving architecture, engineering, manufacturing requirements, utilities, and GMP considerations.

As a Pharma Engineering Firm, Collabtec can support manufacturers with:

• Pharmaceutical facility planning
• GMP-oriented architectural planning
• Manufacturing and process-area planning
• Cleanroom and controlled-area planning
• QC and laboratory planning
• HVAC and MEP coordination
• Utility planning
• Equipment and process coordination
• New facility development
• Brownfield expansion and upgrades
• Engineering coordination and project support

The objective is not simply to create a building that accommodates manufacturing.

It is to develop a facility where quality-driven operations can be planned, executed, maintained, monitored, and scaled effectively.

Building for Compliance Starts With Better Planning

The Maharashtra FDA action highlights how weaknesses across manufacturing practices, documentation, quality control, infrastructure, and facility maintenance can create serious regulatory consequences.

However, it is equally important to recognize that facility design alone does not determine GMP compliance.

GMP is the result of an integrated system involving:

People + Processes + Facility + Equipment + Utilities + Quality Systems + Documentation

A well-designed facility cannot compensate for poor manufacturing practices or inadequate documentation. Similarly, strong quality procedures can be undermined if the physical environment does not adequately support manufacturing, cleaning, environmental control, or material movement.

For this reason, GMP should be considered throughout the complete project lifecycle.

Plan Your Pharmaceutical Facility With Collabtec

For manufacturers planning a new pharmaceutical facility, expansion, or GMP-focused upgrade, early engineering and facility planning can help identify potential risks before they become expensive problems.

Collabtec brings together pharmaceutical facility planning, Plant Engineering, cleanroom planning, laboratory requirements, utilities, and engineering coordination to support practical and scalable manufacturing environments.

The focus is on connecting manufacturing requirements with the physical infrastructure needed to support them effectively.

Ultimately, GMP should not be something a facility tries to accommodate just before an inspection.

It should be part of the thinking that shapes the facility from day one.

Meet Collabtec at PharmaTech & LabTech Expo 2026

Have a pharmaceutical facility challenge you’d like to discuss?

Whether you are planning a new pharmaceutical manufacturing facility, GMP upgrade, cleanroom, laboratory, expansion, or brownfield redevelopment, connect with the Collabtec team at PharmaTech & LabTech Expo 2026.

📅 20–22 August 2026
📍 Helipad Exhibition Centre, Gandhinagar, Gujarat

Bring your project challenge. Let’s discuss how better planning and engineering can support your next pharmaceutical facility.

Meet Collabtec at the expo and let’s talk about pharma facilities.